As the race to build ever more powerful artificial intelligence systems accelerates, one of the industry's leading players is ...

One reason Recursion Pharmaceuticals could become a big deal is that its goal is to usher a paradigm shift into the pharmaceutical industry. Even with impressive technological progress over the past ...

Anthropic's research suggests AI is increasingly used to develop and improve new AI systems, with Claude now writing over 80% ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...